HNNA:NASDAQHennessy Advisors, Inc. Analysis
Data as of 2026-06-17 - not real-time
$9.88
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Hennessy Advisors (HNNA) trades at $9.88, comfortably above its 20‑day SMA of $9.996 but below the 200‑day SMA of $10.10, indicating a neutral medium‑term trend. RSI sits at 47.5, suggesting neither overbought nor oversold conditions, while the MACD histogram remains negative, hinting at modest bearish momentum. The stock is priced well below its DCF fair value of $14.07 and its PE ratio of 9.3 is significantly under the industry average of 17.1, supporting an undervalued view. Volume has been decreasing, and the beta of 0.36 points to low systematic risk, though the 30‑day volatility of ~25% and thin trading (≈2,000 shares daily) raise liquidity concerns.
Dividend yield is attractive at 6.07% with a payout ratio near 53%, and the balance sheet shows ample cash ($73M) relative to debt ($40M), suggesting the dividend is sustainable. Overall, the fundamentals are solid, valuation is attractive, but short‑term technical signals are mixed, making a cautious but optimistic stance appropriate.
Dividend yield is attractive at 6.07% with a payout ratio near 53%, and the balance sheet shows ample cash ($73M) relative to debt ($40M), suggesting the dividend is sustainable. Overall, the fundamentals are solid, valuation is attractive, but short‑term technical signals are mixed, making a cautious but optimistic stance appropriate.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- MACD remains bearish with a negative histogram
- Decreasing volume signals reduced short‑term buying pressure
- Current price above immediate support but below resistance
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation upside versus DCF fair value
- Low beta and modest volatility relative to market
- Sustainable high dividend yield supporting total return
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong cash position and manageable debt level
- Consistent earnings and operating margins
- Undervalued multiples relative to industry peers
Key Metrics & Analysis
Financial Health
Revenue Growth-12.30%
Profit Margin25.40%
P/E Ratio9.3
ROE8.59%
ROA4.38%
Debt/Equity40.49
P/B Ratio0.8
Op. Cash Flow$10.8M
Free Cash Flow$6.0M
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI47.5
Support$9.63
Resistance$10.60
MA 20$10.00
MA 50$9.96
MA 200$10.10
MACDBearish
VolumeDecreasing
Fear & Greed Index92.13
Valuation
Fair Value$14.07
GradeUndervalued
TypeBlend
Dividend Yield6.07%
Risk Assessment
Beta0.36
Volatility25.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.